Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2003
12/04/2003WO2003099792A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099766A1 (2s)-2-ethylphenylpropionic acid derivative
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099276A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
12/04/2003WO2003074485A3 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors
12/04/2003WO2003070728A3 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
12/04/2003WO2003062200A3 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
12/04/2003WO2003059875A3 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
12/04/2003WO2003059807A3 Crystalline solids of carvedilol and processes for their preparation
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003020280A3 Compositions and use thereof in the treatment of cancer
12/04/2003US20030225289 Optical isomers of tricyclic amino alcohol derivatives including 2-(N-(2-(9H-carbazol-2-yloxy)ethyl))amino-1-((3-methylsulfonylamino)- phenyl)ethanol; reduction of a 2-bromo-1-(3-nitrophenyl)ethanone, epoxidation; aminosulfonation
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225152 Such as 3-phenylaminomethylene-1,3-dihydroindol-2-one; use treating cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases
12/04/2003US20030225149 Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
12/04/2003US20030225127 Heterocyclic sulfonamide derivatives
12/04/2003US20030225109 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy
12/04/2003US20030225105 New linear cyclic ureas
12/04/2003US20030225090 Oxindole derivatives
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225080 Treating a disorder responsive to the blockade of sodium channels
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030225036 E.g., 2-(5-Amino-1H-pyrrolo(2,3-c)pyridin-2-yl)-4,6-dichlorophenol and 2-(5-Amino-3-benzyl-1H-pyrrolo(2,3-c)pyridin-2-yl)-4,6-dichlorophenol; utility as anti-coagulants
12/04/2003CA2486962A1 Compounds
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367063A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1367062A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1367061A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1367052A2 Intermediate for the preparation of carvedilol
12/03/2003EP1367051A2 Inhibitors of tumor necrosis factor alpha
12/03/2003EP1367050A1 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate therefor
12/03/2003EP1194375B1 Synthetic porous crystalline mcm-68, its synthesis and use
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/02/2003US6657224 Organic light emitting diode devices using thermostable hole-injection and hole-transport compounds
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656902 Acetonitrile eluent
12/02/2003US6656451 Indole compounds as novel dyes for organ function monitoring
12/02/2003US6656446 Using carbon dioxide soluble secondary alcohol, free radical initiator and oxygen in carbon dioxide
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
12/02/2003CA2193705C Merocyanine dye protein stains
11/2003
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097635A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl(amine-derived)] compounds and analogues thereof, and to products obtained therefrom
11/27/2003WO2003097634A1 Process for producing quinolonecarboxylic acid derivative
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097598A1 Compound exhibiting pgd 2 receptor antagonism
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097044A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003WO2003097042A1 Pgd2 receptor antagonist
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097031A1 Obesity preventive or ameliorator containing methylidene hydrazide compound as active ingredient
11/27/2003WO2003037338A3 Modulators of the cholesterol biosynthetic pathway
11/27/2003WO2003024899A3 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2003004091A3 Aromatic sulfenates for type i phototherapy
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220501 A chemical intermediates for making phthalimidoamlodipine, and further deprotecting to form amlodipine calcium channel blockers
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220397 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220377 Administering to a mammal a therapeutically effective amount of an indole compound to antagonize or agonize the esterogen receptor in the mammal
11/27/2003US20030220369 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220340 Aryl and heteroaryl compounds as antibacterial and antifungal agents
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220323 Such as (2-(4-(2-(1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy)-1-phenyl-ethyl) -piperazin-1-yl)-ethoxy)-acetic acid; for prevention and/or treatment of conditions associated with pathogical levels of substance P
11/27/2003US20030220319 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030220227 Bone disorders, cardiovascular diseases, anticholesterol agents, hypertriglyceridemia, vasomotor disorders, urogenital disorders, prostatic hypertrophy, endometrial hyperplasia, anticarcinogenic agents; CNS disorders; side effect reduced
11/27/2003US20030219662 Electrophotographic organophotoreceptors with novel charge transport compounds
11/27/2003CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003CA2485212A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/27/2003CA2484324A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/26/2003EP1364942A1 Indoline derivative and process for producing the same
11/26/2003EP1363915A1 Substituted calix (4) pyrroles and process for the synthesis of calix (4) pyrroles over molecular sieve catalysts
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363908A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO 3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM
11/26/2003EP1363903A1 Indole derivatives and their use as gnrh antagonists
11/26/2003EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
11/26/2003EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/26/2003EP1363624A2 Fluoro oxindole derivatives as modulators of kcnq potassium channels
11/26/2003EP0923546B1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 458